Clinitech Laboratory Ltd
CTLLABClinitech Laboratory Ltd
CTLLAB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 5.07 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Clinitech Laboratory Ltd provides diagnostic and healthcare tests through centers in Thane and Navi Mumbai, offering over 150 types of tests including biochemistry and microbiology.
Peers
Compare with peersPoly Medicure Ltd
Tarsons Products Ltd
Borosil Scientific Ltd
PREVEST DENPRO LTD
Balaxi Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.59 | 6.45 | 6.37 | 6.44 | — | |||||
Raw Materials | 1.02 | 1.45 | 1.17 | 1.10 | — | |||||
| Power & Fuel Cost | 0.07 | 0.09 | 0.08 | 0.09 | ||||||
| Employee Cost | 0.92 | 1.38 | 1.55 | 1.92 | ||||||
| Selling & Administrative Expenses | 1.40 | 1.99 | 1.90 | 1.98 | ||||||
| Operating & Other expenses | 0.32 | 0.41 | 0.29 | 0.31 | ||||||
EBITDA | 0.86 | 1.13 | 1.38 | 1.04 | — | |||||
| Depreciation/Amortization | 0.25 | 0.38 | 0.45 | 0.44 | — | |||||
| PBIT | 0.61 | 0.75 | 0.93 | 0.60 | — | |||||
| Interest & Other Items | 0.08 | 0.06 | 0.07 | 0.09 | — | |||||
| PBT | 0.53 | 0.69 | 0.86 | 0.51 | — | |||||
| Taxes & Other Items | 0.14 | 0.19 | 0.25 | 0.13 | — | |||||
| Net Income | 0.39 | 0.50 | 0.61 | 0.38 | — | |||||
| EPS | 2.60 | 3.33 | 4.07 | 2.39 | — | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Clinitech Laboratory Ltd | 47.38 | 5.07 | — |
| Poly Medicure Ltd | 116.46 | 20.46 | 0.10% |
| Tarsons Products Ltd | 53.78 | 3.74 | 0.46% |
| Borosil Scientific Ltd | 69.45 | 4.35 | — |
Price Comparison
Compare CTLLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.52%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jan 2024
Jul 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CTLLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
The scrip was listed at Rs 115, a premium of 19.79% over the initial public offer (IPO) price. The stock is currently frozen in its upper limit of 5% over its listing price. The counter hit a high of Rs 120.75 and a low of Rs 110. About 3.23 lakh shares of the company changed hands at the counter. Clinitech Laboratory's IPO was subscribed 36.99 times. The issue opened for bidding on 25 July 2024 and it closed on 29 July 2024. The price of the IPO was fixed at Rs 96 per share. The IPO comprised fresh issue of 6,02,400 equity shares. The promoter and promoter group shareholding diluted to 61.57% from 83.65% pre-issue. The company intends to utilize the net proceeds for expansion of diagnostic centres and general corporate purpose. Clinitech Laboratory is a diagnostic services company with 8 centers in Thane and Navi Mumbai. They offer over 150 types of medical tests, including blood work, immunology, and pathology. The company employs 85 people. The company recorded revenue from operations of Rs 6.43 crore and net profit of Rs 0.37 crore for the period as on 31 March 2024. Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant